Glossary · Clinical

Allograft

An allograft is bone or soft tissue harvested from a human donor (typically a cadaver) and transplanted into a different patient to support structural repair or fusion. It is distinct from an autograft, which uses tissue from the patient's own body.

Verified May 8, 2026 · 7 sources ↓

Drawn from CMSAAPCSelecthealthAaomsNIH

Definition

Source · Editorial summary grounded in 7 cited references ↓

In orthopedic surgery, an allograft refers to donor-derived biological material—most commonly bone, tendon, or cartilage—obtained from a deceased human donor, processed by a tissue bank, and implanted into a recipient patient. Allografts are used when the patient's own tissue is insufficient in quantity or quality, or when harvesting autograft would add operative morbidity. Common orthopedic applications include spinal fusion augmentation, anterior cruciate ligament (ACL) reconstruction, osteochondral defect restoration, and limb-salvage procedures after tumor resection.

Allografts are supplied in several forms that directly determine both clinical use and billing pathway. Morselized (cancellous chip) allograft is packed into voids or used as a fusion extender. Structural allograft maintains load-bearing integrity and is used when mechanical support is required—for example, as a cortical strut or intercalary segment. Fresh osteochondral allograft (OCA) is a specialized form used to resurface cartilage defects and requires careful size-matching and timing due to chondrocyte viability constraints. Processing methods—fresh, fresh-frozen, or freeze-dried (lyophilized)—affect both graft properties and storage requirements.

Tissue bank screening and processing are regulated by the FDA under 21 CFR Part 1271. Allografts carry a low but non-zero risk of disease transmission and immune-mediated rejection responses; modern screening protocols have reduced these risks substantially. From a reimbursement standpoint, the form and anatomic application of the allograft determine which CPT add-on code applies, making accurate operative documentation essential for correct claim submission.

Why it matters

Selecting the wrong CPT add-on code for an allograft can trigger claim denial, underpayment, or a post-payment audit. For spine surgery alone, the difference between reporting a morselized allograft (CPT 20930, a 'B' status code that many payers do not separately reimburse) versus a structural allograft (CPT 20931) versus a threaded bone dowel or cage (CPT 22851) can mean the difference between zero reimbursement and several hundred dollars per claim. The CMS NCCI Policy Manual further specifies that CPT 20931, 20937, and 20938 each carry an MUE of one unit per operative session regardless of how many vertebral levels are fused—so over-reporting units will result in automatic line-item denial. Misidentifying an allograft as a prosthetic device (or vice versa) compounds the error and raises upcoding risk.

Common mistakes

Where people most often go wrong with this concept.

Source · Editorial brief grounded in cited references ↓

  • Reporting CPT 20931 (structural allograft) when only a threaded bone dowel was used—the AMA clarified in CPT Assistant (February 2005) that threaded bone dowels map to CPT 22851, not 20931.
  • Billing CPT 20930 (morselized allograft) without confirming the payer's coverage status; many commercial payers and some Medicare contractors assign 'B' (bundled/non-covered) status to this code.
  • Reporting multiple units of CPT 20931, 20937, or 20938 for multilevel spine fusions—CMS NCCI MUE values cap each of these codes at one unit per operative session regardless of levels treated.
  • Confusing allograft with a prosthetic implant (e.g., PEEK or titanium cage): cages and mesh devices report under CPT 22851, not under the 20930–20931 allograft series.
  • Using CPT codes 21210 or 21215 to report simple socket-preservation or minor bone grafting procedures that do not meet the intensity and reconstruction criteria those codes require—a documented audit concern for inappropriate crosswalking.
  • Failing to document the specific form of allograft (morselized vs. structural) in the operative note, leaving coders without the information needed to distinguish between applicable codes.
  • Assuming allograft and autograft codes are interchangeable; they are separate CPT families (20930–20931 for allograft vs. 20936–20939 for autograft) with different harvesting, documentation, and reimbursement rules.

Related codes

Codes commonly involved when this concept appears in practice.

CPT

ICD-10

M51.16 M17.11

Modifiers

52 Reduced services 59 Distinct procedural service LT Left side RT Right side

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 7 cited references ↓

01What is the difference between a morselized and a structural allograft?
A morselized allograft consists of small cancellous bone chips or particles used to fill voids or augment fusion; it does not provide load-bearing support. A structural allograft is cortical or corticocancellous bone that maintains mechanical integrity and is used where compressive or tensile strength is required. The distinction determines whether CPT 20930 or 20931 applies in spine surgery.
02Why is CPT 20930 often not reimbursed by commercial payers?
Many commercial payers, including some Medicare Advantage plans, assign 'B' (bundled or non-covered as a separate service) status to CPT 20930, treating morselized allograft as integral to the primary fusion procedure. Always verify the specific payer's fee schedule and coverage policy before reporting 20930 as a separately billable line item.
03Can I bill two units of CPT 20931 when the surgeon performs a two-level spinal fusion with structural allograft at each level?
No. The CMS NCCI Policy Manual explicitly sets the MUE for CPT 20931 at one unit per operative session, regardless of the number of vertebral levels fused. Reporting more than one unit will result in an automatic line-item denial under Medicare and most payers that follow NCCI MUE logic.
04When should CPT 22851 be used instead of CPT 20931?
CPT 22851 is correct when the surgeon places a threaded bone dowel, a spinal cage, ovoid mesh, or titanium mesh—these are classified as prosthetic devices, not bone allografts. CPT 20931 applies to all other structural bone allografts. The AMA's CPT Assistant (February 2005) is the controlling guidance on this distinction.
05Is modifier 52 ever required for allograft procedures?
Yes. Modifier 52 (reduced service) should be appended when the operating surgeon does not personally harvest or prepare the graft—for example, when a pre-processed allograft from a tissue bank is used and no separate harvesting procedure is performed by the surgeon. This reflects a reduction in the physician's work relative to the full code descriptor.
06What regulatory body governs allograft tissue banks in the United States?
The FDA regulates human tissue for transplantation under 21 CFR Part 1271, which establishes requirements for donor screening, infectious disease testing, processing, labeling, and storage. Accreditation bodies such as the American Association of Tissue Banks (AATB) provide additional voluntary quality standards that most hospital procurement programs require.
07Does an allograft carry any risk of disease transmission?
Yes, though modern tissue bank screening has reduced this risk dramatically. Residual risks include transmission of bacterial contamination and, rarely, viral pathogens not detected during standard screening windows. Surgeons and patients should be informed of these risks during the consent process, and operative documentation should note the tissue bank source and lot number for traceability.

Sources & references

Editorial content was developed using the following public sources. Last verified May 8, 2026.

  1. 01
    cms.gov
    https://www.cms.gov/files/document/2025nccimedicarepolicymanualcompletepdf.pdf
  2. 02
    cms.gov
    https://www.cms.gov/medicare/coding-billing/national-correct-coding-initiative-ncci-edits/medicare-ncci-policy-manual
  3. 03
    aapc.com
    https://www.aapc.com/codes/coding-newsletters/my-orthopedic-coding-alert/collect-accurate-payment-for-spine-allograft-every-time-article
  4. 04
    selecthealth.org
    https://selecthealth.org/content/dam/selecthealth/Provider/PDFs/policies/medical-coding-reimbursement/cr-57-grafts-during-spinal-surgery.pdf
  5. 05
    aaoms.org
    https://aaoms.org/wp-content/uploads/2024/04/BoneGrafts_CodingPaper.pdf
  6. 06
    pmc.ncbi.nlm.nih.gov
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6937533/
  7. 07AMA CPT Assistant, February 2005 (allograft vs. prosthetic device distinction for spine surgery)

Mira AI Scribe

When Mira detects allograft documentation in an orthopedic operative note, it should prompt the coder or surgeon to confirm three things before code selection: (1) the anatomic site (spine vs. non-spine), (2) the physical form of the graft (morselized/cancellous chips, structural/cortical, or threaded bone dowel), and (3) whether any prosthetic device such as a cage, PEEK spacer, or titanium mesh was placed instead of or alongside the allograft. For spine cases: morselized allograft → CPT 20930 (verify payer coverage; frequently non-reimbursable); structural allograft → CPT 20931; threaded bone dowel, cage, or mesh → CPT 22851. Each of CPT 20931, 20937, and 20938 is subject to an NCCI MUE of 1 unit per operative session—Mira should flag any attempt to bill multiple units for multilevel procedures. For non-spine cases (e.g., ACL reconstruction with allograft tendon, osteochondral resurfacing): confirm the appropriate primary procedure code is driving the claim; the allograft material itself may be captured within the primary code or billed separately depending on the payer's policy. Fresh OCA cases typically require prior authorization documentation—Mira should flag missing PA status before the claim is generated. Modifier 52 applies when the surgeon does not personally harvest the graft tissue. Modifier 59 may be needed to bypass NCCI PTP bundling edits when the allograft add-on is reported alongside a primary fusion or reconstruction code. Always verify payer-specific policies; some payers follow CMS NCCI and some maintain independent coverage determinations for allograft codes.

See Mira's approach

Related terms

Autograft Clinical

An autograft is tissue—most commonly bone, tendon, or cartilage—harvested from the same patient who will receive it, eliminating rejection risk and providing the biologic stimulus for successful incorporation.

Ready?

Ready to transform your orthopedic practice?

See how orthopedic practices are running documentation, billing, and operations on a single voice-first platform.

Get started for free